This meta-analysis aimed to reveal the potential biomarkers of AD, which is known as a progressive neurodegenerative disorder, characterized by the accumulation of amyloid beta and neurofibrillary tangles of hyperphosphorylated tau proteins. The gene discussed is MAPT; the disease is Alzheimer disease.